Eligible Medicare members can now access select FDA-approved GLP-1 medications including Wegovy and Zepbound through the Medicare GLP-1 Bridge Program, running July 1, 2026 through December 31, 2027
Semaglutide, by contrast, is a GLP-1 receptor agonist that slows gastric emptying, enhances insulin secretion, and directly signals fullness to the brain through a different hormonal pathway
Progressing to Moderate Doses As doses increase, appetite suppression typically becomes more noticeable
Metabolism: Clinical and Experimental, 46 (4), 410413
Gastrointestinal side effects are reduced by starting the GLP-1 RA at a low dose and titrating up over a certain duration according to each product labelling
Interestingly, mitochondrial dysfunctionmanifested by elevated mitochondrial calcium levels, increased ROS, reduced membrane potential, and lower pHalong with the recruitment of autophagic machinery, such as the accumulation of Parkin on mitochondria, precedes peripheral fission (Kleele et al., 2021)